Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halburns: Albumin for Hypoalbuminemia in Burn Patients
NCT01436292Phase 4Withdrawn
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Sep 2011
- Primary completion
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in hypoalbuminemia, sponsored by Centre hospitalier de l’Université de Montréal. Planned start Sep 2011; status: withdrawn.
02
Drugs
albumin (human)
03
Conditions
hypoalbuminemia
Beyond the preview
Go deeper on NCT01436292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01436292.